- 米国企業
- Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc.KPTI
時価総額
$1.3億
PER
2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Product | - | - | - | - | - | - | 76 | 98 | 120 |
License and Other | - | - | - | - | - | - | 32 | 111 | 37 |
Revenue from Contract with Customer, Excluding Assessed Tax | 1 | 0 | 0 | 0 | - | 30 | 108 | 210 | 157 |
Cost of sales | - | - | - | - | - | - | - | - | 5 |
Research and development | 53 | 60 | 98 | 87 | 107 | 161 | 151 | 161 | 149 |
Selling, general and administrative | - | - | - | - | - | - | 126 | 144 | 145 |
Total operating expenses | 64 | 76 | 119 | 111 | 132 | 210 | 280 | 308 | 299 |
Loss from operations | -34 | -76 | -119 | -111 | -131 | -180 | -172 | -98 | -142 |
Interest income | 0 | 0 | 1 | 1 | 2 | 4 | 3 | 1 | 2 |
Interest expense | 0 | 0 | - | - | - | 2 | 27 | 26 | 25 |
Other (expense) income, net | 0 | 0 | -0 | 0 | -0 | -0 | 0 | -0 | -0 |
Total other expense, net | - | - | 1 | 1 | 2 | 2 | -24 | -26 | -23 |
Loss before income taxes | - | - | - | -109 | -129 | -178 | -196 | -124 | -165 |
Income tax provision | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Net loss | - | - | -118 | -110 | -129 | -178 | -196 | -124 | -165 |
Earnings Per Share, Basic | - | - | - | - | - | - | - | - | -2.02 |
Earnings Per Share, Diluted | - | - | - | - | - | - | - | - | -2.02 |